BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 102 filers reported holding BELLICUM PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.33 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $119,820,000 | -21.9% | 35,555 | +42.8% | 0.00% | – |
| Q3 2018 | $153,384,000 | -16.5% | 24,900 | 0.0% | 0.00% | – |
| Q2 2018 | $183,762,000 | +20.7% | 24,900 | +7.3% | 0.00% | – |
| Q1 2018 | $152,192,000 | +72719.1% | 23,200 | +121.0% | 0.00% | – |
| Q3 2016 | $209,000 | +53.7% | 10,500 | 0.0% | 0.00% | – |
| Q2 2016 | $136,000 | +38.8% | 10,500 | 0.0% | 0.00% | – |
| Q1 2016 | $98,000 | -95.3% | 10,500 | -88.3% | 0.00% | -100.0% |
| Q1 2015 | $2,078,000 | -0.6% | 89,700 | -1.1% | 0.00% | 0.0% |
| Q4 2014 | $2,090,000 | – | 90,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| X-Square Capital, LLC | 22,374 | $105,000 | 0.10% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |